Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 5, pp. 1815-1820
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines
Yusha Araf, F. Akter, Yan‐Dong Tang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1825-1832
Open Access | Times Cited: 781
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 93
Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern
Asif Shajahan, Lauren E. Pepi, Bhoj Kumar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
Kexin Yan, Troy Dumenil, Tang Bing, et al.
Virus Evolution (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 30
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3521-3539
Open Access | Times Cited: 29
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
SubbaRao V. Tulimilli, Siva Dallavalasa, Chaithanya G. Basavaraju, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1751-1751
Open Access | Times Cited: 28
Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage
Changqing Yu, Guosheng Wang, Qiang Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 18
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Immunomodulatory role of metalloproteinase ADAM17 in tumor development
Kai Wang, Zixue Xuan, Xiaoyan Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
Letian Fang, Jie Xu, Yue Zhao, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2
Fei Yu, Xiaoqing Liu, Hailan Ou, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 4
Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
Narasimha M. Beeraka, Olga Sukocheva, Elena Lukina, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 20
Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner
Meng Chen, Menghang Wang, Xue-Gang Shen, et al.
Journal of Virology (2022) Vol. 96, Iss. 20
Open Access | Times Cited: 19
Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization
Haijun Tang, Long Gao, Zhao Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Update on Omicron variant and its threat to vulnerable populations
Bowen Dai, Wangquan Ji, Peiyu Zhu, et al.
Public Health in Practice (2024) Vol. 7, pp. 100494-100494
Open Access | Times Cited: 3
In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain
Christopher A. Beaudoin, Arun Prasad Pandurangan, So Yeon Kim, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4181-4192
Open Access | Times Cited: 18
Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
Jonathan Bordat, Sébastien Maury, Mathieu Leclerc
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Hung Van Nguyen, Hoang Linh Nguyen, Pham Dang Lan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 18, pp. 6497-6553
Closed Access | Times Cited: 9
SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice
Shi‐Jian Song, Heeyeon Kim, Eun Young Jang, et al.
Plant Biotechnology Journal (2022) Vol. 20, Iss. 12, pp. 2298-2312
Open Access | Times Cited: 14
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin
Pilar Somovilla, Carlos García‐Crespo, Brenda Martínez‐González, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 1
Open Access | Times Cited: 8
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations
Birong Cao, Xiaoxi Wang, Wanchao Yin, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 2
Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Gi Uk Jeong, Insu Hwang, Wooseong Lee, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1221-1229
Open Access | Times Cited: 2
Site Specific N- and O-glycosylation mapping of the Spike Proteins of SARS-CoV-2 Variants of Concern
Asif Shajahan, Lauren E. Pepi, Bhoj Kumar, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 10
NSP6 inhibits the production of ACE2-containing exosomes to promote SARS-CoV-2 infectivity
Xi Lv, Ran Chen, Taizhen Liang, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top